The Immunomodulatory Functions of Mesenchymal Stromal/Stem Cells Mediated via Paracrine Activity

Friedenstein, 1970, The Development of Fibroblast Colonies in Monolayer Cultures of Guinea-Pig Bone Marrow and Spleen Cells, Cell Prolif., 3, 393, 10.1111/j.1365-2184.1970.tb00347.x

Mcelreavey, 1991, Isolation, culture and characterisation of fibroblast-like cells derived from the Wharton’s jelly portion of human umbilical cord, Biochem. Soc. Trans., 19, 29S, 10.1042/bst019029s

Noort, 2003, Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential, Haematologica, 88, 845

Gruber, 2010, Human Adipose-Derived Mesenchymal Stem Cells: Direction to a Phenotype Sharing Similarities with the Disc, Gene Expression Profiling, and Coculture with Human Annulus Cells, Tissue Eng. Part A, 16, 2843, 10.1089/ten.tea.2009.0709

Ponnaiyan, 2012, Comparison of Immuno-Phenotypes of Stem Cells from Human Dental Pulp and Periodontal Ligament, Int. J. Immunopathol. Pharmacol., 25, 127, 10.1177/039463201202500115

HORWITZ, 2005, Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement, Cytotherapy, 7, 393, 10.1080/14653240500319234

Pittenger, 1999, Multilineage Potential of Adult Human Mesenchymal Stem Cells, Science, 284, 143, 10.1126/science.284.5411.143

Krebsbach, 1999, Bone Marrow Stromal Cells: Characterization and Clinical Application, Crit. Rev. Oral Biol. Med., 10, 165, 10.1177/10454411990100020401

Chagastelles, 2006, Mesenchymal stem cells reside in virtually all post-natal organs and tissues, J. Cell Sci., 119, 2204, 10.1242/jcs.02932

Arthur, 2009, The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair, J. Cell. Physiol., 218, 237, 10.1002/jcp.21592

Asanuma, 2010, Therapeutic Applications of Mesenchymal Stem Cells to Repair Kidney Injury, J. Urol., 184, 26, 10.1016/j.juro.2010.03.050

Liang, 2014, Paracrine Mechanisms of Mesenchymal Stem Cell-Based Therapy: Current Status and Perspectives, Cell Transplant., 23, 1045, 10.3727/096368913X667709

Corcione, 2006, Human mesenchymal stem cells modulate B-cell functions, Blood, 107, 367, 10.1182/blood-2005-07-2657

Montesinos, 2015, Immunoregulation by mesenchymal stem cells: Biological aspects and clinical applications, J. Immunol. Res., 2015, 394917

Murphy, 2013, Mesenchymal stem cells: Environmentally responsive therapeutics for regenerative medicine, Exp. Mol. Med., 45, e54, 10.1038/emm.2013.94

Caplan, 2016, MSCs: The Sentinel and Safe-Guards of Injury, J. Cell. Physiol., 231, 1413, 10.1002/jcp.25255

Kern, 2006, Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, or Adipose Tissue, Stem Cells, 24, 1294, 10.1634/stemcells.2005-0342

Amable, 2014, Protein synthesis and secretion in human mesenchymal cells derived from bone marrow, adipose tissue and Wharton’s jelly, Stem Cell Res. Ther., 5, 53, 10.1186/scrt442

Gnecchi, 2005, Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells, Nat. Med., 11, 367, 10.1038/nm0405-367

Lin, 2013, Stem cell therapy: An exercise in patience and prudence, Philos. Trans. R. Soc. B Biol. Sci., 368, 20110334, 10.1098/rstb.2011.0334

Najar, M., Bouhtit, F., Melki, R., Afif, H., Hamal, A., Fahmi, H., Merimi, M., and Lagneaux, L. (2019). Mesenchymal Stromal Cell-Based Therapy: New Perspectives and Challenges. J. Clin. Med., 8.

Yip, 2017, Therapeutic effects of adipose-derived mesenchymal stem cells against brain death-induced remote organ damage and post-heart transplant acute rejection, Oncotarget, 8, 108692, 10.18632/oncotarget.21433

Uzunel, 2006, Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease, Transplantation, 81, 1390, 10.1097/01.tp.0000214462.63943.14

Kopen, 1999, Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains, Proc. Natl. Acad. Sci. USA, 96, 10711, 10.1073/pnas.96.19.10711

Meier, 2013, Transplantation of mesenchymal stem cells for the treatment of liver diseases, is there enough evidence?, Stem Cell Res., 11, 1348, 10.1016/j.scr.2013.08.011

Matthay, 2010, Mesenchymal stem cells for acute lung injury: Preclinical evidence, Crit. Care Med., 38, S569, 10.1097/CCM.0b013e3181f1ff1d

Bhansali, 2009, Efficacy of Autologous Bone Marrow-Derived Stem Cell Transplantation in Patients with Type 2 Diabetes Mellitus, Stem Cells Dev., 18, 1407, 10.1089/scd.2009.0164

Yan, 2016, Mesenchymal stem cells alleviate experimental rheumatoid arthritis through microRNA-regulated IκB expression, Sci. Rep., 6, 28915, 10.1038/srep28915

Teixeira, 2016, Modulation of the Mesenchymal Stem Cell Secretome Using Computer-Controlled Bioreactors: Impact on Neuronal Cell Proliferation, Survival and Differentiation, Sci. Rep., 6, 27791, 10.1038/srep27791

Heathman, 2016, Characterization of human mesenchymal stem cells from multiple donors and the implications for large scale bioprocess development, Scale-Manuf. Cell-Based Ther. IV, 108, 14

Orlic, 2001, Bone marrow cells regenerate infarcted myocardium, Nature, 410, 701, 10.1038/35070587

Strauer, 2002, Repair of Infarcted Myocardium by Autologous Intracoronary Mononuclear Bone Marrow Cell Transplantation in Humans, Circulation, 106, 1913, 10.1161/01.CIR.0000034046.87607.1C

Assmus, 2002, Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI), Circulation, 106, 3009, 10.1161/01.CIR.0000043246.74879.CD

Hu, 2005, Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms, Am. J. Physiol.-Ren. Physiol., 289, F31, 10.1152/ajprenal.00007.2005

Takahashi, 2006, Cytokines produced by bone marrow cells can contribute to functional improvement of the infarcted heart by protecting cardiomyocytes from ischemic injury, Am. J. Physiol.-Heart Circ. Physiol., 291, H886, 10.1152/ajpheart.00142.2006

Leiker, 2008, Assessment of a nuclear affinity labeling method for tracking implanted mesenchymal stem cells, Cell Transplant., 17, 911, 10.3727/096368908786576444

Murry, 2004, Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts, Nature, 428, 664, 10.1038/nature02446

Gnecchi, 2006, Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement, FASEB J., 20, 661, 10.1096/fj.05-5211com

Lee, 2009, Intravenous hMSCs Improve Myocardial Infarction in Mice because Cells Embolized in Lung Are Activated to Secrete the Anti-inflammatory Protein TSG-6, Cell Stem Cell, 5, 54, 10.1016/j.stem.2009.05.003

Shabbir, 2009, Heart failure therapy mediated by the trophic activities of bone marrow mesenchymal stem cells: A noninvasive therapeutic regimen, Am. J. Physiol. Heart Circ. Physiol., 296, H1888, 10.1152/ajpheart.00186.2009

Nakamura, 2015, Mesenchymal-stem-cell-derived exosomes accelerate skeletal muscle regeneration, FEBS Lett., 589, 1257, 10.1016/j.febslet.2015.03.031

Shao, 2017, MiRNA-Sequence Indicates That Mesenchymal Stem Cells and Exosomes Have Similar Mechanism to Enhance Cardiac Repair, BioMed Res. Int., 2017, 4150705, 10.1155/2017/4150705

Juneja, 1986, Role of marrow stromal cells in the establishment of a transformed lymphoblastic B-cell line from a normal human subject, Leuk. Res., 10, 1209, 10.1016/0145-2126(86)90239-0

Cselenyák, A., Pankotai, E., Horváth, E.M., Kiss, L., and Lacza, Z. (2010). Mesenchymal stem cells rescue cardiomyoblasts from cell death in an in vitro ischemia model via direct cell-to-cell connections. BMC Cell Biol., 11.

Gatti, 2011, Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia–reperfusion-induced acute and chronic kidney injury, Nephrol. Dial. Transplant., 26, 1474, 10.1093/ndt/gfr015

Islam, 2012, Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury, Nat. Med., 18, 759, 10.1038/nm.2736

Magni, 2002, Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli, Blood, 99, 3838, 10.1182/blood.V99.10.3838

Unanue, 1984, Antigen-Presenting Function of the Macrophage, Annu. Rev. Immunol., 2, 395, 10.1146/annurev.iy.02.040184.002143

Murray, 2011, Protective and pathogenic functions of macrophage subsets, Nat. Rev. Immunol., 11, 723, 10.1038/nri3073

Wynn, 2013, Macrophage biology in development, homeostasis and disease, Nature, 496, 445, 10.1038/nature12034

Leelahavanichkul, 2008, Bone marrow stromal cells attenuate sepsis via prostaglandin E2-dependent reprogramming of host macrophages to increase their interleukin-10 production, Nat. Med., 15, 42

Ren, 2012, CCR2-Dependent Recruitment of Macrophages by Tumor-Educated Mesenchymal Stromal Cells Promotes Tumor Development and Is Mimicked by TNFα, Cell Stem Cell, 11, 812, 10.1016/j.stem.2012.08.013

Cao, 2014, Transplantation of mesenchymal stem cells recruits trophic macrophages to induce pancreatic beta cell regeneration in diabetic mice, Int. J. Biochem. Cell Biol., 53, 372, 10.1016/j.biocel.2014.06.003

Abumaree, 2013, Human Placental Mesenchymal Stem Cells (pMSCs) Play a Role as Immune Suppressive Cells by Shifting Macrophage Differentiation from Inflammatory M1 to Anti-inflammatory M2 Macrophages, Stem Cell Rev. Rep., 9, 620, 10.1007/s12015-013-9455-2

Zhang, 2004, Effects of Mesenchymal Stem Cells on Differentiation, Maturation, and Function of Human Monocyte-Derived Dendritic Cells, Stem Cells Dev., 13, 263, 10.1089/154732804323099190

Nauta, 2006, Mesenchymal Stem Cells Inhibit Generation and Function of Both CD34+-Derived and Monocyte-Derived Dendritic Cells, J. Immunol., 177, 2080, 10.4049/jimmunol.177.4.2080

Djouad, 2007, Mesenchymal Stem Cells Inhibit the Differentiation of Dendritic Cells Through an Interleukin-6-Dependent Mechanism, Stem Cells, 25, 2025, 10.1634/stemcells.2006-0548

Liu, 2014, MSCs inhibit bone marrow-derived DC maturation and function through the release of TSG-6, Biochem. Biophys. Res. Commun., 450, 1409, 10.1016/j.bbrc.2014.07.001

English, 2008, Murine mesenchymal stem cells suppress dendritic cell migration, maturation and antigen presentation, Immunol. Lett., 115, 50, 10.1016/j.imlet.2007.10.002

Chiesa, 2011, Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells, Proc. Natl. Acad. Sci. USA, 108, 17384, 10.1073/pnas.1103650108

Mantovani, 2011, Neutrophils in the activation and regulation of innate and adaptive immunity, Nat. Rev. Immunol., 11, 519, 10.1038/nri3024

Raffaghello, 2008, Human Mesenchymal Stem Cells Inhibit Neutrophil Apoptosis: A Model for Neutrophil Preservation in the Bone Marrow Niche, Stem Cells, 26, 151, 10.1634/stemcells.2007-0416

Yu, 2016, TNFα-activated mesenchymal stromal cells promote breast cancer metastasis by recruiting CXCR2+ neutrophils, Oncogene, 36, 482, 10.1038/onc.2016.217

Brandau, S., Jakob, M., Bruderek, K., Bootz, F., Giebel, B., Radtke, S., Mauel, K., Jäger, M., Flohé, S.B., and Lang, S. (2014). Mesenchymal Stem Cells Augment the Anti-Bacterial Activity of Neutrophil Granulocytes. PLoS ONE, 9.

Jiang, 2016, Suppression of Neutrophil-Mediated Tissue Damage—A Novel Skill of Mesenchymal Stem Cells, Stem Cells, 34, 2393, 10.1002/stem.2417

Ljunggren, 2016, Emerging insights into natural killer cells in human peripheral tissues, Nat. Rev. Immunol., 16, 310, 10.1038/nri.2016.34

Spaggiari, 2006, Mesenchymal stem cell-natural killer cell interactions: Evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation, Blood, 107, 1484, 10.1182/blood-2005-07-2775

Sotiropoulou, 2006, Interactions Between Human Mesenchymal Stem Cells and Natural Killer Cells, Stem Cells, 24, 74, 10.1634/stemcells.2004-0359

Spaggiari, 2008, Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: Role of indoleamine 2,3-dioxygenase and prostaglandin E2, Blood, 111, 1327, 10.1182/blood-2007-02-074997

Selmani, 2008, Human Leukocyte Antigen-G5 Secretion by Human Mesenchymal Stem Cells Is Required to Suppress T Lymphocyte and Natural Killer Function and to Induce CD4+CD25highFOXP3+ Regulatory T Cells, Stem Cells, 26, 212, 10.1634/stemcells.2007-0554

Thomas, 2014, Interaction with mesenchymal stem cells provokes natural killer cells for enhanced IL-12/IL-18-induced interferon-gamma secretion, Mediators Inflamm., 2014, 143463, 10.1155/2014/143463

Boissel, 2008, Umbilical Cord Mesenchymal Stem Cells Increase Expansion of Cord Blood Natural Killer Cells. Biol, Blood Marrow Transplant., 14, 1031, 10.1016/j.bbmt.2008.06.016

Janeway, C.J., Travers, P., and Walport, M. (2008). T cell-mediated cytotoxicity. Immunobiology: The Immune System in Health and Disease, Taylor & Francis Group. [5th ed.].

Duffy, 2011, Mesenchymal stem cell effects on T-cell effector pathways, Stem Cell Res. Ther., 2, 34, 10.1186/scrt75

Meisel, 2004, Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase–mediated tryptophan degradation, Blood, 103, 4619, 10.1182/blood-2003-11-3909

Ryan, 2007, Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells, Clin. Exp. Immunol., 149, 353, 10.1111/j.1365-2249.2007.03422.x

Aggarwal, 2005, Human mesenchymal stem cells modulate allogeneic immune cell responses, Blood, 105, 1815, 10.1182/blood-2004-04-1559

Liotta, 2008, Toll-Like Receptors 3 and 4 Are Expressed by Human Bone Marrow-Derived Mesenchymal Stem Cells and Can Inhibit Their T-Cell Modulatory Activity by Impairing Notch Signaling, Stem Cells, 26, 279, 10.1634/stemcells.2007-0454

Bae, 2006, Role of Toll-Like Receptors on Human Adipose-Derived Stromal Cells, Stem Cells, 24, 2744, 10.1634/stemcells.2006-0189

Morad, 2007, Toll-like receptors and their ligands control mesenchymal stem cell functions, Blood, 109, 1422, 10.1182/blood-2006-06-028704

English, 2009, Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells, Clin. Exp. Immunol., 156, 149, 10.1111/j.1365-2249.2009.03874.x

Wang, 2009, Bone Marrow-Derived Mesenchymal Stem Cells Inhibit Acute Rejection of Rat Liver Allografts in Association with Regulatory T-Cell Expansion, Transplant. Proc., 41, 4352, 10.1016/j.transproceed.2009.08.072

Rafei, 2009, Mesenchymal Stromal Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Inhibiting CD4 Th17 T Cells in a CC Chemokine Ligand 2-Dependent Manner, J. Immunol., 182, 5994, 10.4049/jimmunol.0803962

Tatara, 2011, Mesenchymal stromal cells inhibit Th17 but not regulatory T-cell differentiation, Cytotherapy, 13, 686, 10.3109/14653249.2010.542456

Chiossone, 2016, Mesenchymal Stromal Cells Induce Peculiar Alternatively Activated Macrophages Capable of Dampening Both Innate and Adaptive Immune Responses, Stem Cells, 34, 1909, 10.1002/stem.2369

Liu, 2007, B lymphocyte-directed immunotherapy promotes long-term islet allograft survival in nonhuman primates, Nat. Med., 13, 1295, 10.1038/nm1673

Franquesa, 2012, Immunomodulatory effect of mesenchymal stem cells on B cells, Front. Immunol., 3, 212, 10.3389/fimmu.2012.00212

Crawford, 2006, Primary T Cell Expansion and Differentiation In Vivo Requires Antigen Presentation by B Cells, J. Immunol., 176, 3498, 10.4049/jimmunol.176.6.3498

Ng, 2010, B cells help alloreactive T cells differentiate into memory T cells, Am. J. Transplant., 10, 1970, 10.1111/j.1600-6143.2010.03223.x

Healy, 2015, Mesenchymal Stromal Cells Protect Against Caspase 3-Mediated Apoptosis of CD19+ Peripheral B Cells Through Contact-Dependent Upregulation of VEGF, Stem Cells Dev., 24, 2391, 10.1089/scd.2015.0089

Barrio, 2014, Human adipose tissue-derived mesenchymal stromal cells promote B-cell motility and chemoattraction, Cytotherapy, 16, 1692, 10.1016/j.jcyt.2014.07.012

Tabera, 2008, The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes, Haematologica, 93, 1301, 10.3324/haematol.12857

Che, 2014, Impaired B Cell Inhibition by Lupus Bone Marrow Mesenchymal Stem Cells Is Caused by Reduced CCL2 Expression, J. Immunol., 193, 5306, 10.4049/jimmunol.1400036

Ji, 2012, Mesenchymal Stem Cells Support Proliferation and Terminal Differentiation of B Cells, Cell. Physiol. Biochem., 30, 1526, 10.1159/000343340

Day, 2015, Granulocyte colony-stimulating factor reprograms bone marrow stromal cells to actively suppress B lymphopoiesis in mice, Blood, 125, 3114, 10.1182/blood-2015-02-629444

Colombo, 2014, Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles, Annu. Rev. Cell Dev. Biol., 30, 255, 10.1146/annurev-cellbio-101512-122326

Biancone, 2012, Therapeutic potential of mesenchymal stem cell-derived microvesicles, Nephrol. Dial. Transplant., 27, 3037, 10.1093/ndt/gfs168

Katsuda, 2013, The therapeutic potential of mesenchymal stem cell-derived extracellular vesicles, Proteomics, 13, 1637, 10.1002/pmic.201200373

Morrison, 2017, Mesenchymal Stromal Cells Modulate Macrophages in Clinically Relevant Lung Injury Models by Extracellular Vesicle Mitochondrial Transfer, Am. J. Respir. Crit. Care Med., 196, 1275, 10.1164/rccm.201701-0170OC

Chamberlain, 2019, Extracellular Vesicle-Educated Macrophages Promote Early Achilles Tendon Healing, Stem Cells, 37, 652, 10.1002/stem.2988

Willis, 2018, Mesenchymal Stromal Cell Exosomes Ameliorate Experimental Bronchopulmonary Dysplasia and Restore Lung Function through Macrophage Immunomodulation, Am. J. Respir. Crit. Care Med., 197, 104, 10.1164/rccm.201705-0925OC

Reverberi, 2017, Mesenchymal Stem Cell-Derived Extracellular Vesicles as Mediators of Anti-Inflammatory Effects: Endorsement of Macrophage Polarization, Stem Cells Transl. Med., 6, 1018, 10.1002/sctm.16-0363

Holopainen, 2018, Mesenchymal Stromal Cells and Their Extracellular Vesicles Enhance the Anti-Inflammatory Phenotype of Regulatory Macrophages by Downregulating the Production of Interleukin (IL)-23 and IL-22, Front. Immunol., 9, 771, 10.3389/fimmu.2018.00771

Reis, 2018, Mesenchymal Stromal Cell-Derived Extracellular Vesicles Attenuate Dendritic Cell Maturation and Function, Front. Immunol., 9, 2538, 10.3389/fimmu.2018.02538

Luciano, 2015, Immunoregulatory Effects of Mesenchymal Stem Cell-Derived Extracellular Vesicles on T Lymphocytes, Cell Transplant., 24, 2615, 10.3727/096368915X687543

Budoni, 2013, The Immunosuppressive Effect of Mesenchymal Stromal Cells on B Lymphocytes is Mediated by Membrane Vesicles, Cell Transplant., 22, 369, 10.3727/096368911X582769b

Zhang, 2013, Mesenchymal Stem Cells Secrete Immunologically Active Exosomes, Stem Cells Dev., 23, 1233, 10.1089/scd.2013.0479

Wen, 2016, Mesenchymal stem cell and derived exosome as small RNA carrier and Immunomodulator to improve islet transplantation, J. Control. Release, 238, 166, 10.1016/j.jconrel.2016.07.044

Tamura, 2016, Immunosuppressive effect of mesenchymal stem cell-derived exosomes on a concanavalin A-induced liver injury model, Inflamm. Regen., 36, 26, 10.1186/s41232-016-0030-5

Wen, 2016, Mesenchymal stromal cell-derived extracellular vesicles rescue radiation damage to murine marrow hematopoietic cells, Leukemia, 30, 2221, 10.1038/leu.2016.107

Bruno, 2017, Renal Regenerative Potential of Different Extracellular Vesicle Populations Derived from Bone Marrow Mesenchymal Stromal Cells, Tissue Eng. Part A, 23, 1262, 10.1089/ten.tea.2017.0069

Rasmusson, 2004, Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells, Lancet, 363, 1439, 10.1016/S0140-6736(04)16104-7

Frassoni, 2008, Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase II study, Lancet, 371, 1579, 10.1016/S0140-6736(08)60690-X

Prasad, 2011, Efficacy and Safety of Ex Vivo Cultured Adult Human Mesenchymal Stem Cells (ProchymalTM) in Pediatric Patients with Severe Refractory Acute Graft-Versus-Host Disease in a Compassionate Use Study, Biol. Blood Marrow Transplant., 17, 534, 10.1016/j.bbmt.2010.04.014

Kurtzberg, 2014, Allogeneic Human Mesenchymal Stem Cell Therapy (Remestemcel-L, Prochymal) as a Rescue Agent for Severe Refractory Acute Graft-versus-Host Disease in Pediatric Patients, Biol. Blood Marrow Transplant., 20, 229, 10.1016/j.bbmt.2013.11.001

Goedecke, 2008, Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium, Bone Marrow Transplant., 43, 245

Lucchini, 2010, Platelet-lysate-Expanded Mesenchymal Stromal Cells as a Salvage Therapy for Severe Resistant Graft-versus-Host Disease in a Pediatric Population, Biol. Blood Marrow Transplant., 16, 1293, 10.1016/j.bbmt.2010.03.017

Ciccocioppo, 2011, Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn’s disease, Gut, 60, 788, 10.1136/gut.2010.214841

Forbes, 2014, A Phase 2 Study of Allogeneic Mesenchymal Stromal Cells for Luminal Crohn’s Disease Refractory to Biologic Therapy, Clin. Gastroenterol. Hepatol., 12, 64, 10.1016/j.cgh.2013.06.021

Dhere, 2016, The safety of autologous and metabolically fit bone marrow mesenchymal stromal cells in medically refractory Crohn’s disease—A phase 1 trial with three doses, Aliment. Pharmacol. Ther., 44, 471, 10.1111/apt.13717

Bonab, 2007, Does Mesenchymal Stem Cell Therapy Help Multiple Sclerosis Patients? Report of a Pilot Study, Iran. J. Immunol., 4, 50

Yamout, 2010, Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: A pilot study, J. Neuroimmunol., 227, 185, 10.1016/j.jneuroim.2010.07.013

Connick, 2012, Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: An open-label phase 2a proof-of-concept study, Lancet Neurol., 11, 150, 10.1016/S1474-4422(11)70305-2

Mesples, 2013, Early immunotherapy using autologous adult stem cells reversed the effect of anti-pancreatic islets in recently diagnosed type 1 diabetes mellitus: Preliminary results, Med. Sci. Monit. Int. Med. J. Exp. Clin. Res., 19, 852

Carlsson, 2015, Preserved β-Cell Function in Type 1 Diabetes by Mesenchymal Stromal Cells, Diabetes, 64, 587, 10.2337/db14-0656

Kim, 2017, Clinical Trial of Human Umbilical Cord Blood-Derived Stem Cells for the Treatment of Moderate-to-Severe Atopic Dermatitis: Phase I/IIa Studies, Stem Cells, 35, 248, 10.1002/stem.2401

Ferrara, 2009, Graft-versus-host disease, Lancet Lond. Engl., 373, 1550, 10.1016/S0140-6736(09)60237-3

Lee, 2018, Immunomodulatory mechanisms of mesenchymal stem cells and their therapeutic applications, Spec. Issue Stem Cell Immunol., 326, 68, 10.1016/j.cellimm.2017.08.009

Ciccocioppo, 2015, Long-Term Follow-Up of Crohn Disease Fistulas After Local Injections of Bone Marrow–Derived Mesenchymal Stem Cells, Mayo Clin. Proc., 90, 747, 10.1016/j.mayocp.2015.03.023

Dulamea, 2015, Mesenchymal stem cells in multiple sclerosis—Translation to clinical trials, J. Med. Life, 8, 24

Freitag, J., Bates, D., Boyd, R., Shah, K., Barnard, A., Huguenin, L., and Tenen, A. (2016). Mesenchymal stem cell therapy in the treatment of osteoarthritis: Reparative pathways, safety and efficacy—A review. BMC Musculoskelet. Disord., 17.